» Articles » PMID: 21705975

Disturbances of Biomarkers of Iron and Oxidant-antioxidant Homeostasis in Patients with Beta-thalassemia Intermedia

Overview
Date 2011 Jun 28
PMID 21705975
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Disturbances of oxidative stress and antioxidant status have been reported in patients with Β-ThM and in a limited number of patients with ThI.

Objectives: To I) study relevant biomarkers of iron metabolism, oxidative stress and antioxidant status, in untransfused patients with ThI and II) evaluate the relation of changes in biomarkers to the clinicalhematological phenotype and genotype.

Design: Biomarkers of iron metabolism (ferritin, NTBI, sTfR), of oxidant activity (MDA, GSSG, GSSC/GSHT, NO) and of antioxidant enzymes (GR, GPx, SOD) and Vitamins (E, C, A) were estimated and analyzed in 20 controls and 33 patients with ThI, sub-classified into mild (17) and severe (16) types. All but five were untransfused.

Results: Clinical phenotypes of mild and severe ThI were related to distinct genotypes, 11 for mild and 14 for severe. The three iron biomarkers were significantly increased in both ThI types compared to controls and in severe compared to mild types. The ferritin levels (total iron load) had a highly significant positive correlation with age (p〈0.001) and sTfR. Biomarkers with oxidant activity were also significantly increased in ThI patients compared to controls; significantly higher levels for MDA, NTBI, and GSSG/GSHT were found in severe ThI. The activity of antioxidant enzymes GR, GP and SOD, was significantly significantly reduced in patients, especially in the severe type. Vitamin C was mildly reduced in both types of ThI.

Conclusions: Activity of relevant biomarkers of iron and oxidant-antioxidant homeostasis was significantly increased in untransfused patients with ThI. These changes coincide with the severity of clinical phenotype, genotype and bone marrow erythroid activity evaluated by sTfR levels.

Citing Articles

The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major.

Ibrahim H, Zakaria S, El-Batch M, El-Shanshory M, Alrayes Z, Kabel A Biomedicines. 2022; 10(10).

PMID: 36289866 PMC: 9599077. DOI: 10.3390/biomedicines10102601.


Polyneuropathy Associated with Severe Iron Overload and Oxidative Stress in β-Thalassemia Patients.

El-Tagui M, Salama K, El-Sabbagh M, Youness E, Ragaey M, Abdel-Salam A Indian J Hematol Blood Transfus. 2019; 35(3):518-522.

PMID: 31388267 PMC: 6646492. DOI: 10.1007/s12288-018-1050-x.


The Effect of Transfusion-Dependent Thalassemia Patient's Serum on Peripheral Blood Mononuclear Cell Viability.

Patpan N, Banjerdpongchai R, Tantiworawit A, Poofery J, Komonrit P, Fanhchaksai K J Cell Death. 2019; 12:1179066018823534.

PMID: 30670921 PMC: 6327338. DOI: 10.1177/1179066018823534.


Foxo3 gene expression and oxidative status in beta-thalassemia minor subjects.

Lazarte S, Monaco M, Teran M, Haro A, Achem M, Isse B Rev Bras Hematol Hemoter. 2017; 39(2):115-121.

PMID: 28577647 PMC: 5457465. DOI: 10.1016/j.bjhh.2017.01.005.


β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals.

Musharraf S, Iqbal A, Ansari S, Parveen S, Khan I, Siddiqui A Sci Rep. 2017; 7:42249.

PMID: 28198811 PMC: 5304209. DOI: 10.1038/srep42249.